Barclays’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.59M | Buy |
382,966
+182,977
| +91% | +$1.71M | ﹤0.01% | 1836 |
|
|
2025
Q1 | $2.46M | Buy |
199,989
+3,938
| +2% | +$48.4K | ﹤0.01% | 1893 |
|
|
2024
Q4 | $2.59M | Buy |
196,051
+8,422
| +4% | +$111K | ﹤0.01% | 2041 |
|
|
2024
Q3 | $3.61M | Buy |
187,629
+110,535
| +143% | +$2.13M | ﹤0.01% | 1753 |
|
|
2024
Q2 | $1.58M | Sell |
77,094
-25,078
| -25% | -$515K | ﹤0.01% | 1852 |
|
|
2024
Q1 | $2.43M | Sell |
102,172
-153,705
| -60% | -$3.66M | ﹤0.01% | 1813 |
|
|
2023
Q4 | $5.53M | Sell |
255,877
-166,131
| -39% | -$3.59M | ﹤0.01% | 1418 |
|
|
2023
Q3 | $6.13M | Buy |
422,008
+252,813
| +149% | +$3.67M | ﹤0.01% | 1044 |
|
|
2023
Q2 | $3.54M | Sell |
169,195
-812,691
| -83% | -$17M | ﹤0.01% | 1416 |
|
|
2023
Q1 | $20.7M | Buy |
981,886
+18,550
| +2% | +$392K | 0.01% | 586 |
|
|
2022
Q4 | $24.5M | Buy |
963,336
+687,577
| +249% | +$17.5M | 0.01% | 580 |
|
|
2022
Q3 | $6.63M | Buy |
275,759
+271,168
| +5,907% | +$6.52M | 0.01% | 970 |
|
|
2022
Q2 | $88K | Sell |
4,591
-69,643
| -94% | -$1.33M | ﹤0.01% | 3518 |
|
|
2022
Q1 | $1.29M | Sell |
74,234
-701,242
| -90% | -$12.2M | ﹤0.01% | 2114 |
|
|
2021
Q4 | $17M | Buy |
775,476
+373,088
| +93% | +$8.17M | 0.01% | 723 |
|
|
2021
Q3 | $7.69M | Buy |
402,388
+345,050
| +602% | +$6.59M | ﹤0.01% | 1018 |
|
|
2021
Q2 | $984K | Sell |
57,338
-14,821
| -21% | -$254K | ﹤0.01% | 2121 |
|
|
2021
Q1 | $1.61M | Buy |
72,159
+61,976
| +609% | +$1.39M | ﹤0.01% | 2032 |
|
|
2020
Q4 | $226K | Sell |
10,183
-3,061
| -23% | -$67.9K | ﹤0.01% | 2653 |
|
|
2020
Q3 | $196K | Sell |
13,244
-36,404
| -73% | -$539K | ﹤0.01% | 2756 |
|
|
2020
Q2 | $736K | Buy |
49,648
+40,707
| +455% | +$603K | ﹤0.01% | 2103 |
|
|
2020
Q1 | $99K | Sell |
8,941
-16,000
| -64% | -$177K | ﹤0.01% | 2837 |
|
|
2019
Q4 | $218K | Buy |
24,941
+9,997
| +67% | +$87.4K | ﹤0.01% | 3136 |
|
|
2019
Q3 | $111K | Sell |
14,944
-2,881
| -16% | -$21.4K | ﹤0.01% | 3348 |
|
|
2019
Q2 | $167K | Buy |
17,825
+8,603
| +93% | +$80.6K | ﹤0.01% | 3299 |
|
|
2019
Q1 | $48K | Sell |
9,222
-2,630
| -22% | -$13.7K | ﹤0.01% | 3669 |
|
|
2018
Q4 | $52K | Sell |
11,852
-6,081
| -34% | -$26.7K | ﹤0.01% | 3166 |
|
|
2018
Q3 | $144K | Buy |
17,933
+7,739
| +76% | +$62.1K | ﹤0.01% | 3226 |
|
|
2018
Q2 | $72K | Buy |
10,194
+2,732
| +37% | +$19.3K | ﹤0.01% | 3185 |
|
|
2018
Q1 | $106K | Buy |
7,462
+785
| +12% | +$11.2K | ﹤0.01% | 3144 |
|
|
2017
Q4 | $58K | Sell |
6,677
-7,727
| -54% | -$67.1K | ﹤0.01% | 3288 |
|
|
2017
Q3 | $168K | Buy |
14,404
+9,360
| +186% | +$109K | ﹤0.01% | 2478 |
|
|
2017
Q2 | $70K | Sell |
5,044
-1,067
| -17% | -$14.8K | ﹤0.01% | 2899 |
|
|
2017
Q1 | $83K | Buy |
6,111
+304
| +5% | +$4.13K | ﹤0.01% | 2915 |
|
|
2016
Q4 | $41K | Buy |
5,807
+170
| +3% | +$1.2K | ﹤0.01% | 2898 |
|
|
2016
Q3 | $85K | Buy |
5,637
+4,839
| +606% | +$73K | ﹤0.01% | 2498 |
|
|
2016
Q2 | $8K | Buy |
+798
| New | +$8K | ﹤0.01% | 3043 |
|